Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Dec;52(12):1167-77.
doi: 10.1007/s00234-010-0771-9. Epub 2010 Sep 28.

Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma

Affiliations
Clinical Trial

Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma

Ulrike Löbel et al. Neuroradiology. 2010 Dec.

Abstract

Introduction: We compared the sensitivity and specificity of T2*-weighted gradient-echo imaging (T2*-GRE) and susceptibility-weighted imaging (SWI) in determining prevalence and cumulative incidence of intratumoral hemorrhages in children with diffuse intrinsic pontine glioma (DIPG) undergoing antiangiogenic and radiation therapy.

Methods: Patients were recruited from an institutional review board-approved prospective phase I trial of vandetanib administered in combination with radiation therapy. Patient consent was obtained before enrollment. Consecutive T2*-GRE and SWI exams of 17 patients (F/M: 9/8; age 3-17 years) were evaluated. Two reviewers (R1 and R2) determined the number and size of hemorrhages at baseline and multiple follow-ups (92 scans, mean 5.4/patient). Statistical analyses were performed using descriptive statistics, graphical tools, and mixed-effects Poisson regression models.

Results: Prevalence of hemorrhages at diagnosis was 41% and 47%; the cumulative incidences of hemorrhages at 6 months by T2*-GRE and SWI were 82% and 88%, respectively. Hemorrhages were mostly petechial; 9.7% of lesions on T2*-GRE and 5.2% on SWI were hematomas (>5 mm). SWI identified significantly more hemorrhages than T2*-GRE did. Lesions were missed or misinterpreted in 36/39 (R1/R2) scans by T2*-GRE and 9/3 scans (R1/R2) by SWI. Hemorrhages had no clinically significant neurological correlates in patients.

Conclusions: SWI is more sensitive than T2*-GRE in detecting hemorrhages and differentiating them from calcification, necrosis, and artifacts. Also, petechial hemorrhages are more common in DIPG at diagnosis than previously believed and their number increases during the course of treatment; hematomas are rare.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

Dr. Alberto Broniscer received the study medication from AstraZeneca. All other authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
T2*-GRE and SWI images that were used for data evaluation. T2*-GRE images included magnitude (a) and phase (b) images; SWI included magnitude (c), phase (d), SWI (e) and minimum intensity projection images (f). For both sequences, the image quality was rated as slight susceptibility artifacts or image deformity without interference.
Figure 2
Figure 2
Cumulative incidence of hemorrhagic lesions in patients who showed a marked nonlinear increase in the number of hemorrhagic lesions during the course of the disease. Results of T2*-GRE scans are displayed in red and those of SWI in black (R1 solid lines, R2 dashed lines). The gray vertical lines represent the time interval of cRT, and the red vertical line the point when the patient was taken off the study. The symbol # above the curves marks scans performed on a 1.5T scanner.
Figure 3
Figure 3
Number of hemorrhagic lesions identified by T2*-GRE and SWI (R1 black circles; R2 red stars). Each circle/star represents the lesion count by T2*-GRE and SWI of a single patient study.
Figure 4
Figure 4
Hemorrhage versus calcification. The two index lesions show identical signal properties on both T2*-GRE magnitude (a) and phase (b) images, suggesting hemorrhagic nature. The SWI magnitude image (c) allows better delineation of the lesions and the corresponding phase image (d) shows that the lesion within the ventral pons corresponds to a petechial hemorrhage, whereas the lesion within left posterolateral pons is likely a calcification because it exhibits a hyposignal (confirmed by CT).
Figure 5
Figure 5
Hemorrhage versus areas of necrosis. T2*-GRE magnitude (a) and phase (b) images suggest a hemorrhagic lesion within the ventral pons. On SWI magnitude (c), the hyposignal is less conspicuous and the corresponding phase image (d) does not show a hypersignal, which formally rules out the presence of deposits of magnetically susceptible substances within the lesion.
Figure 6
Figure 6
SWI images with the phase-encoding direction set from anterior to posterior. Flow artifacts from the basilar artery project directly onto the tumor area on the magnitude image (a) which may lead to misinterpretation. However, the phase image (b) does not show a corresponding hypersignal to indicate a true hemorrhage.
Figure 7
Figure 7
Hematoma versus cluster of petechial hemorrhages. T2*-GRE magnitude (a) and phase (b) images suggest a hematoma. SWI, magnitude (c) and phase (d) images reveal a cluster of petechial hemorrhages within an area of tumor necrosis.

Similar articles

Cited by

References

    1. CBTRUS. Published by the Central Brain Tumor Registry of the United States. 2005. Statistical Report: Primary Brain Tumors in the United States, 1998–2002.
    1. Kaatsch P, Rickert CH, Kuhl L, Schuz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 2001;92:3155–3164. - PubMed
    1. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ. Radiologic classification of brain stem tumors: Correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg. 1996;24:9–23. - PubMed
    1. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7:241–248. - PubMed
    1. Folkman J, Bach M, Rowe JW, Davidoff F, Lambert P, Hirsch C, Goldberg A, Hiatt HH, Glass J, Henshaw E. Tumor Angiogenesis - Therapeutic Implications. N Engl J Med. 1971;285:1182–1186. - PubMed

Publication types

LinkOut - more resources